Group One Trading’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.23M Sell
67,400
-123,100
-65% -$12.4M 0.01% 1137
2025
Q4
$19.5M Sell
190,500
-45,200
-19% -$4.04M 0.03% 568
2025
Q3
$14.7M Buy
235,700
+94,500
+67% +$5.14M 0.03% 667
2025
Q2
$7.35M Buy
141,200
+16,900
+14% +$755K 0.02% 1032
2025
Q1
$5.3M Buy
124,300
+12,200
+11% +$526K 0.02% 1023
2024
Q4
$3.42M Sell
112,100
-8,700
-7% -$245K 0.01% 1448
2024
Q3
$2.77M Sell
120,800
-6,100
-5% -$173K 0.01% 1464
2024
Q2
$3.66M Sell
126,900
-8,300
-6% -$193K 0.01% 1003
2024
Q1
$2.79M Buy
135,200
+37,800
+39% +$810K 0.01% 1250
2023
Q4
$2.63M Sell
97,400
-71,700
-42% -$1.88M 0.01% 1642
2023
Q3
$5.01M Buy
169,100
+23,100
+16% +$812K 0.02% 940
2023
Q2
$5.23M Sell
146,000
-22,900
-14% -$658K 0.02% 926
2023
Q1
$3.96M Sell
168,900
-172,000
-50% -$4.91M 0.01% 995
2022
Q4
$9.27M Buy
340,900
+157,600
+86% +$7.21M 0.02% 780
2022
Q3
$9.87M Buy
183,300
+49,700
+37% +$2.55M 0.02% 736
2022
Q2
$5.39M Buy
133,600
+81,900
+158% +$4.06M 0.01% 1242
2022
Q1
$3.42M Sell
51,700
-46,800
-48% -$3.2M ﹤0.01% 1861
2021
Q4
$9.85M Buy
98,500
+1,900
+2% +$197K 0.01% 1117
2021
Q3
$12.1M Sell
96,600
-20,800
-18% -$2.47M 0.01% 924
2021
Q2
$14.6M Buy
117,400
+19,500
+20% +$2.62M 0.02% 817
2021
Q1
$14.9M Sell
97,900
-32,800
-25% -$4.96M 0.02% 687
2020
Q4
$16.8M Buy
130,700
+47,000
+56% +$5.41M 0.03% 530
2020
Q3
$9.36M Sell
83,700
-6,300
-7% -$576K 0.03% 555
2020
Q2
$7.3M Buy
90,000
+52,200
+138% +$4.21M 0.03% 582
2020
Q1
$2.63M Sell
37,800
-25,000
-40% -$1.92M 0.02% 868
2019
Q4
$4.91M Sell
62,800
-79,800
-56% -$5.75M 0.03% 707
2019
Q3
$9.1M Buy
142,600
+98,800
+226% +$8.7M 0.07% 310
2019
Q2
$3.78M Buy
43,800
+25,600
+141% +$1.96M 0.03% 683
2019
Q1
$1.4M Buy
+18,200
New +$1.01M 0.02% 1180

Other funds holding GH

Group One Trading's GH Position: Q3 2025 in Review

Group One Trading sold out of Guardant Health (GH) in Q3 2025, closing a stake of 3,375 shares — an estimated $184K sold.

Group One Trading first reported a position in GH in Q2 2019 and held it in 16 quarters. The position peaked at $13.1M in Q1 2021. 394 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Group One Trading reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 3,375 Guardant Health shares in Q3 2025, an estimated $184K.
  • Group One Trading first reported a position in Guardant Health in Q2 2019 and held it in 16 quarters.
  • Group One Trading's Guardant Health position peaked at $13.1M in Q1 2021.
  • 394 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.